Article Information
History
- August 5, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Jingyan Yang, DrPH, MHS1,2,*,
- Kathleen M. Andersen, PhD, MSc, BSc1,
- Kiran K. Rai, PhD, MSc, BSc3,
- Theo Tritton, MSc, BSc3,
- Tendai Mugwagwa, PhD, MSc, BSc4,
- Carmen Tsang, PhD, MSc, BSc4,
- Maya Reimbaeva, MS1,
- Leah J. McGrath, PhD, MHS1,
- Poppy Payne, MPH, BSc3,
- Bethany Backhouse, MSc, BSc3,
- Diana Mendes, PhD, MSc, PharmD4,
- Rebecca Butfield, MPH4,
- Robert Wood, BSc3 and
- Jennifer L. Nguyen, ScD, MPH, MHCI1
- 1Pfizer Inc., New York, United States
- 2Institute for Social and Economic Research and Policy, Columbia University, New York, NY, USA
- 3Adelphi Real World, Bollington, United Kingdom
- 4Pfizer Ltd, Tadworth, United Kingdom
- ↵*Corresponding Author:
Jingyan Yang, DrPH MHS, Jingyan.yang{at}pfizer.com, Global Value and Access, Pfizer Inc., 66 Hudson Blvd E, New York, NY 10001, USA